'Seeing through a glass darkly': casting light on imidazoline 'I' sites. (Q48368646)

11 February 2018

review article

1 reference

title

'Seeing through a glass darkly': casting light on imidazoline 'I' sites. (English)

1 reference

11 February 2018

0 references

2

1 reference

11 February 2018

author name string

Eglen RM

1

1 reference

11 February 2018

Kendall DA

3

1 reference

11 February 2018

Nutt DJ

4

1 reference

11 February 2018

Morgan NG

5

1 reference

11 February 2018

Wilson VG

6

1 reference

11 February 2018

Dillon MP

7

1 reference

11 February 2018

publication date

1 September 1998

1 reference

11 February 2018

Trends in Pharmacological Sciences

published in

1 reference

11 February 2018

volume

19

1 reference

11 February 2018

page(s)

381-390

1 reference

11 February 2018

issue

9

1 reference

11 February 2018

Receptor interactions of imidazolines: alpha-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

The elusive family of imidazoline binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Imidazoline receptors and their endogenous ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Characterization of the imidazoline binding site involved in regulation of insulin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

I1 agents: a new approach to the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

The stimulatory effect of clonidine through imidazoline receptors on locus coeruleus noradrenergic neurones is mediated by excitatory amino acids and modulated by serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

New therapeutic agents for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Mediation of the hypotensive action of systemic clonidine in the rat by alpha 2-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

New approaches to antiglaucoma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Centrally mediated ocular hypotension: potential role of imidazoline receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Reduction in focal cerebral ischemia by agents acting at imidazole receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Protection against ischemia-induced neuronal damage by the alpha 2-adrenoceptor antagonist idazoxan: influence of time of administration and possible mechanisms of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

[3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

[3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

[3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Localization of the imidazoline binding domain on monoamine oxidase B

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: regulation by I2 imidazoline ligands in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Decreased number and immunoreactivity of I2-imidazoline receptors in the frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Imidazoline binding sites in Huntington's and Parkinson's disease putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Decreased density of I2-imidazoline receptors in the postmortem brain of heroin addicts.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Noradrenergic mechanisms in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Functional studies of specific imidazoline-2 receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

BU-224 produces spinal antinociception as an agonist at imidazoline I2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

An I2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Modulation of opioid analgesia by agmatine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Role of alpha 2-adrenoceptors and imidazoline-binding sites in the control of insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Phentolamine block of KATP channels is mediated by Kir6.2.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Insulin Secretagogues with an Imidazoline Structure Inhibit Arginine-Induced Glucagon Secretion from Isolated Rat Islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Imidazoli(di)ne compounds interact with the phencyclidine site of NMDA receptors in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Isolation and partial purification of a clonidine-displacing endogenous brain substance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferens.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

A low molecular weight brain substance interacts, similarly to clonidine, with alpha 2-adrenoceptors of human platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Evidence for a bioactive clonidine-displacing substance in peripheral tissues and serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Clonidine-displacing substance (CDS) and its putative imidazoline receptor. New leads for further divergence of alpha 2-adrenergic receptor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Identifying clonidine-displacing substance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Identification of ligands selective for central I2-imidazoline binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Agmatine: an endogenous clonidine-displacing substance in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Central cardiovascular actions of agmatine, a putative clonidine-displacing substance, in conscious rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Cardiovascular effects of agmatine, a "clonidine-displacing substance", in conscious rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

Further observations on the action of beta-iminazolylethylamine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901244-9

7 January 2021

10.1016/S0165-6147(98)01244-9

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9786027

1 reference

11 February 2018